Krishnan, A., Kaiser, M., Popat, R., Matous, J., Garfall, A., Vega, G., Perrot, A., Anguille, S., Oriol, A., Kint, N., Caers, J., Usmani, S., Karlin, L., Sanchez, L., Varga, C., Roeloffzen, W., Dachs, L. R., Pan, D., Rodriguez-Otero, P., Mateos, M., Ishida, T., Fukushima, K., Minnick, P., Smit, M. D., Daskalakis, N., Prior, T., Vishwamitra, D., DeSantis, E., Nguyen, A., Hilder, B., Weidman, J., Hodin, C., Jonathan, D., Lee, S., Touzeau, C., Lee, H., Donk, N. W. V. D., Minnema, M. (2025). Updated efficacy and safety results of JNJ-5322, a novel, next-generation BCMA×GPRC5D×CD3 trispecific antibody, in patients with Relapsed/Refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-4042